STOCKHOLDER AGREEMENTStockholder Agreement • September 13th, 2022 • Vickers Vantage Corp. I • Biological products, (no disgnostic substances) • Delaware
THIS STOCKHOLDER AGREEMENT (this “Agreement”), dated as of September 12 2022, is made and entered into by and among Vickers Vantage Corp. I, a Cayman Islands exempted company (which shall migrate to and domesticate as a Delaware corporation prior to the Closing, the “Company”), and Sorrento Therapeutics, Inc., a Delaware corporation (“Stockholder”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Merger Agreement (as defined below).
THIRD AMENDMENT TO EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN SCILEX PHARMACEUTICALS, INC. AND CARDINAL HEALTH 105, LLCExclusive Distribution Agreement • September 13th, 2022 • Vickers Vantage Corp. I • Biological products, (no disgnostic substances)
This Third Amendment to Exclusive Distribution Agreement (the “Amendment”) is made as of this 1st day of October, 2021 (the “Effective Date”), between Scilex Pharmaceuticals, Inc., a Delaware corporation, with an address of 960 San Antonio Road, Palo Alto, CA 94303 (“Client”), and Cardinal Health 105, LLC (f.k.a. Cardinal Health 105, Inc.), an Ohio limited liability company, with a place of business at 501 Mason Road, Suite 200, La Vergne, Tennessee, 37086 (“Cardinal Health”) each individually a (“Party”) and collectively (the “Parties”).
CONTRIBUTION AND SATISFACTION OF INDEBTEDNESS AGREEMENTContribution and Satisfaction of Indebtedness Agreement • September 13th, 2022 • Vickers Vantage Corp. I • Biological products, (no disgnostic substances) • California
This CONTRIBUTION AND SATISFACTION OF INDEBTEDNESS AGREEMENT (this “Agreement”), entered into as of September 12, 2022 (the “Agreement Date”), is by and among SORRENTO THERAPEUTICS, INC., a Delaware corporation (the “Sorrento”), SCILEX HOLDING COMPANY, a direct wholly owned subsidiary of Sorrento (“Scilex”), and SCILEX PHARMACEUTICALS, INC., an indirect wholly owned subsidiary of Sorrento and direct wholly owned subsidiary of Scilex (“Scilex Pharma”).
SECOND AMENDMENT TO EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • September 13th, 2022 • Vickers Vantage Corp. I • Biological products, (no disgnostic substances)
This Second Amendment to Exclusive Distribution Agreement (the “Amendment”) is made as of this 19th day of September, 2018 (the “Effective Date”), between SCILEX Pharmaceuticals Inc., a Delaware corporation, with an address of 27201 Puerta Real, Suite 235, Mission Viejo, CA 92691 (“Client”), and Cardinal Health 105, Inc., an Ohio corporation, with a place of business at 501 Mason Road, Suite 200, La Vergne, Tennessee, 37086 (“Cardinal Health”) each individually a (“Party”) and collectively (the “Parties”).
AMENDMENT TO EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN SCILEX PHARMACEUTICALS INC. AND CARDINAL HEALTH 105, INC.Exclusive Distribution Agreement • September 13th, 2022 • Vickers Vantage Corp. I • Biological products, (no disgnostic substances)
This Amendment to the Exclusive Distribution Agreement (“Amendment”) is dated effective as of the 24th day of May, 2018 (“Effective Date”) and is by and between Scilex Pharmaceuticals Inc. (“Client”) and Cardinal Health 105, Inc. (“Cardinal Health”) referred to each individually as a “Party” and collectively as the “Parties”.
Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) information that the Registrant treats as private or confidential. Such omitted information is indicated by brackets (“[...***...]”) in this...Exclusive Distribution Agreement • September 13th, 2022 • Vickers Vantage Corp. I • Biological products, (no disgnostic substances) • Tennessee
This Exclusive Distribution Agreement (the “Agreement”) is made as of this 6th day of August, 2015 (the “Effective Date”), between SCILEX Pharmaceuticals, Inc., a Delaware corporation with an address of 101 Lindenwood Drive, Suite 225, Malvern, PA 19355 (“Client”), and Cardinal Health 105, Inc., an Ohio corporation, with a place of business at 15 Ingram Boulevard, Suite 100, LaVergne, Tennessee, 37086 (“Cardinal Health”) each individually a (“Party”) and collectively (the “Parties”).
